🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.88
-0.10 (-1.43%)
Nov 20, 2026, 2:16 PM EST - Market open

Aura Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
41.6759.5231.6941.06121.58149.06
Short-Term Investments
255.5684.73119.4185.0967.23-
Cash & Short-Term Investments
297.23144.24151.09226.15188.81149.06
Cash Growth
83.63%-4.54%-33.19%19.78%26.66%757.03%
Prepaid Expenses
0.441.671.71.822.172.73
Restricted Cash
---0.020.020.02
Other Current Assets
3.563.837.833.815.71.88
Total Current Assets
303.1149.74160.62231.79196.7153.7
Property, Plant & Equipment
16.5818.4520.592226.046.2
Other Long-Term Assets
1.941.241.291.281.190.13
Total Assets
321.62169.43182.5255.08223.94160.03

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1.721.552.31.792.922.4
Accrued Expenses
16.1513.359.276.954.253.83
Current Portion of Leases
3.323.243.152.692.960.62
Other Current Liabilities
0.150.240.190.940.330.51
Total Current Liabilities
21.3418.3814.9112.3610.467.36
Long-Term Leases
12.8514.1315.6216.8717.90.36
Total Liabilities
34.1932.5230.5329.2328.357.72

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Additional Paid-In Capital
919.9617.43525.93512.62406.56304.45
Retained Earnings
-591.81-480.42-374.23-287.31-210.9-152.14
Comprehensive Income & Other
-1.57-0.10.260.54-0.07-
Total Common Equity
287.43136.91151.97225.85195.58152.32
Shareholders' Equity
287.43136.91151.97225.85195.58152.32
Total Liabilities & Equity
321.62169.43182.5255.08223.94160.03

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
16.1717.3818.7719.5620.860.98
Net Cash (Debt)
281.06126.86132.33206.59167.95148.09
Net Cash Growth
95.03%-4.13%-35.95%23.01%13.41%751.42%
Net Cash Per Share
3.302.102.675.215.6128.70
Filing Date Shares Outstanding
104.0764.1550.2349.537.829.22
Total Common Shares Outstanding
103.9563.595049.3537.7729.21
Working Capital
281.76131.36145.71219.44186.25146.35
Book Value Per Share
2.772.153.044.585.185.21
Tangible Book Value
287.43136.91151.97225.85195.58152.32
Tangible Book Value Per Share
2.772.153.044.585.185.21
Machinery
9.088.988.467.87.435.64
Construction In Progress
0.290.230.270.391.812.37
Leasehold Improvements
0.470.470.47--0.01
SEC Filings: 10-K · 10-Q